This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MorphoSys Yönetim

Yönetim kriter kontrolleri 1/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Arkadius Pichota

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresiless than a year
CEO sahipliğin/a
Yönetim ortalama görev süresiless than a year
Yönetim Kurulu ortalama görev süresi6.5yrs

Son yönetim güncellemeleri

Recent updates

MorphoSys: Hold Rating Until The Novartis Deal Closes

May 01

Novartis And MorphoSys Are A Perfect Match

Feb 06

MorphoSys: Positive Pelabresib Data Finally Unlocking Upside

Jan 18

MorphoSys updates Q2 & FY22 guidance below prior provided levels

Jul 26

MorphoSys May Not Recover From Adventurous Constellation Buyout

May 04

Sierra Oncology's Strong Data In Myelofibrosis Challenges MorphoSys And Incyte

Jan 28

Incyte and MorphoSys presents new three-year data for blood cancer therapy

Jun 04

MorphoSys reports Q1 results

May 05

MorphoSys AG appoints Sangamo 's Sung Lee as new CFO

Jan 06

MorphoSys AG (MOR) Investor Presentation - Slideshow

Dec 08

MorphoSys AG 2020 Q3 - Results - Earnings Call Presentation

Nov 22

MorphoSys reports Q3 results

Nov 11

CEO

Arkadius Pichota

less than a year

Görev süresi

Mr. Arkadius Pichota, Ph D., MBA., is Chief Executive Officer of MorphoSys AG from June 2024. Mr. Pichota served as President, General Manager and Chairman of the Board of the Novartis subsidiary Navigate...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Charlotte Lohmann
Chief Legal and Human Resources Officer & Member of Management Board4.6yrs€1.10m0.0036%
$ 99.7k
Arkadius Pichota
Chief Executive Officerless than a yearVeri yokVeri yok
Lukas Gilgen
Chief Financial Officerless than a yearVeri yokVeri yok
Tim Demuth
Chief Research & Development Officer1.8yrsVeri yokVeri yok
Klaus De Wall
Head of Accounting & Taxno dataVeri yokVeri yok
Margit Urban
Head of Discovery Alliances & Technologiesno dataVeri yokVeri yok
Julia Neugebauer
Head of Investor Relationsno dataVeri yokVeri yok
Barbara Krebs-Pohl
Chief Business Officerno dataVeri yokVeri yok
Günter Wellnhofer
Head of Technical Operationsno dataVeri yokVeri yok
Harald Watzka
Head of Alliance Managementno dataVeri yokVeri yok
Yen Ching Chua
Head of Clinical Operationsno dataVeri yokVeri yok
Kathrin Tissot
Head of Business Teamno dataVeri yokVeri yok

1.0yrs

Ortalama Görev Süresi

Deneyimli Yönetim: MOR's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Bruce Cheson
Member of Scientific Advisory Board7.9yrsVeri yokVeri yok
Gunther Adolf
Member of Scientific Advisory Board7.9yrsVeri yokVeri yok
Sergio Quezada
Member of Scientific Advisory Board7.9yrsVeri yokVeri yok
Raymond Sweet
Member of Scientific Advisory Board7.9yrsVeri yokVeri yok
Sharon Curran
Independent Member of Supervisory Board5.2yrs€92.60kVeri yok
Heinrich V. Moisa
Chairman of the Supervisory Boardless than a yearVeri yokVeri yok
Silke Mainka
Member of the Supervisory Boardless than a yearVeri yokVeri yok
Romain Lege
Deputy Chairman of the Supervisory Boardless than a yearVeri yokVeri yok

6.5yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: MOR's board of directors are considered experienced (6.5 years average tenure).